What is Lumonus?
Lumonus Pty Ltd operates at the intersection of oncology and artificial intelligence, providing a sophisticated platform that automates documentation, treatment planning, and dosimetry. By integrating seamlessly with established EMR, OIS, and TPS systems, the company addresses the critical need for interoperability in radiotherapy. Its market position is defined by its ability to reduce administrative burdens on oncology care teams, thereby allowing clinicians to focus on high-value patient interactions and evidence-based treatment delivery. The company's focus on enhancing the quality and accessibility of cancer care has made it a standout entity in the Australian health-tech ecosystem.
How much funding has Lumonus raised?
Lumonus has raised a total of $16.3M across 1 funding round:
Series B
$16.3M
Series B (2025): $16.3M with participation from Oncology Ventures and Aviron Investments
Key Investors in Lumonus
Oncology Ventures
Oncology Ventures is dedicated to investing in healthcare data companies that address significant challenges in cancer care, focusing on early detection, patient navigation, and AI-powered treatment optimization.
Aviron Investments
Aviron is an independent asset management firm with an extensive and successful track record of investing globally in private equity, real estate, and publicly traded securities.
What's next for Lumonus?
With this latest capital injection, Lumonus is expected to accelerate its international expansion and deepen its product development roadmap. The strategic focus will likely center on enhancing its AI-driven analytics engine to provide more predictive insights into treatment efficacy. As the company transitions from a regional player to a global provider, the focus will remain on scaling its integration capabilities to support larger hospital networks. The backing from specialized healthcare investors suggests a long-term commitment to transforming the oncology care journey, with potential future developments in automated quality assurance and real-time clinical decision support systems.
See full Lumonus company page
